Sort by
Keyphrases
Ovarian Cancer
100%
NK Cell-mediated Killing
37%
DNAM-1
37%
Natural Killer Cells
37%
Nasopharyngeal Swab Testing
37%
SARS-CoV-2 Pandemic
37%
Postoperative Pulmonary Complications
37%
Carbohydrate Antigen 125 (CA125)
37%
Primary Care Population
37%
Swab Test
37%
COVID-19
37%
Human Epididymis Protein 4
37%
Elective Surgery
37%
Residual Tumor Cells
37%
Risk Areas
37%
Ovarian Metastasis
37%
Chromatin Landscape
37%
High-grade Serous Ovarian Cancer (HGSOC)
37%
Post-chemotherapy
37%
Primary Care
31%
Tumor
28%
Pulmonary Complications
28%
Major Surgery
28%
Minor Surgery
28%
Low Risk
28%
Risk of Ovarian Malignancy Algorithm
25%
Chemoresistance
25%
Preoperative Testing
18%
SARS-CoV-2 Infection
18%
Chemotherapy
15%
Clinical Outcomes
15%
Single-cell Chromatin Accessibility
12%
Gene Regulatory Landscape
12%
Diagnostic Accuracy
12%
NR2F6
12%
RORĪ±
12%
HNF4G
12%
E2F2
12%
Neoadjuvant Chemotherapy
12%
Nuclear Receptor
12%
Accessible Chromatin
12%
Transcription Factor Binding Sites
12%
Lymphoid Cells
12%
Cell Surface Display
12%
Ovarian Cancer Cells
12%
Stress-responsive Genes
12%
Myeloid Cells
12%
Chromatin Accessibility
12%
TP63
12%
Proliferative Activity
12%
Medicine and Dentistry
Ovarian Cancer
74%
Natural Killer Cell
37%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Nasopharyngeal Swab
37%
Epididymis
37%
Primary Health Care
37%
Elective Surgery
37%
CA-125
37%
Pandemic
37%
Cancer
27%
Minor Surgery
16%
Major Surgery
16%
Diagnostic Accuracy
12%
Malignant Neoplasm
11%
Neoplasm
10%
Preoperative Testing
10%
Infection
10%
Primary Tumor
8%
General Practitioner
6%
Observational Study
6%
Cancer Diagnosis
6%
Tumor Marker
6%
Metastatic Carcinoma
5%
Diseases
5%
COVID-19
5%
Cancer Surgery
5%
Cohort Analysis
5%
Odds Ratio
5%
